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Prescription Drug Abuse
Olivia Lauer & Laura Bray
Eastern Kentucky University
Abstract: This paper analyzed the prescription drug abuse epidemic among the adolescent
population through a holistic lens. The prescription drug abuse epidemic has been identified as a
national and community healthcare issue due to the harmful physiological effects and alarming
death rates among adolescents in the United States. The current healthcare policies of the federal
government, pharmaceutical companies, and other various organizations were researched in order
to evaluate the progress made to counteract the epidemic. In addition to the progress, the possible
consequences of these newly implemented policies were also reviewed and scrutinized. In response
to the prescription drug abuse epidemic, a physician accountability system was proposed as a
potential solution. It was found that the collaborative effort of healthcare practitioners, along with
new federal guidelines, will decrease access and availability of prescription drugs to adolescents,
thus, decreasing the number of adolescents abusing prescription drugs in the United States.
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According to the National Institute on Drug Abuse
(National Institute of Health [NIH], 2018a), “about 1 in 9 youth
or 11.4 percent of young people aged 12 to 25 used prescription
drugs non-medically within the past year” (para. 2).
Prescription drug abuse includes the usage of prescription drugs
in a dose other than prescribed, taking another individual’s
medication, or taking prescription drugs for a nonmedical use
(NIH, 2018a). Prescription drug abuse can lead to life-threating
medical consequences including, but not limited to, addiction,
depression, seizures, overdose, and death (NIH, 2018b).
National and Community Healthcare issue
Prescription drug abuse is a major public health problem.
National data indicates that the nonmedical use of prescription
drugs has dramatically increased from 2010 to 2018. This
increase is a reflection of the rise in the number of prescriptions
issued by physicians to treat chronic pain (DuPont, 2010). The
three most common classifications of prescription drugs
misused by adolescents are opioids, central nervous system
depressants, and stimulants, such as Adderall (NIH, 2018a).
The misuse of these prescription drugs has severe effects on the
developing brains and bodies of many adolescents. Indeed,
these effects can alter areas of the brain that are critical for basic
functions of life such as heart rate, breathing, and sleeping
(Elliot et al., 2008). Furthermore, the frequency of misuse or
abuse of prescription drugs is highly related to addiction and
other risky behaviors such as smoking and unprotected sexual
activity.
Impacts on Delivery of Healthcare
The World Health Organization (2017) states that “in 2012,
more than 250 million opioid prescriptions were written in the
USA, and according to the Center for Disease Control and
Prevention (CDC), that is more than enough for the entire
population of 319 million people” (p. 318). Indeed, the
prescription drug abuse epidemic appears to be directly related
to physicians increasing their prescribing habits. Therefore, it is
likely that physicians who overprescribe medications are
unintentionally enabling prescription drug abusers. In the case
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of prescription opioids, adolescents who receive a legitimate
prescription from a physician are at an increased risk for future
prescription drug misuse (NIH, 2018a). Physicians must
consider alternatives to opioids, and other addictive
prescription drugs, in order to counterbalance this community
and national healthcare issue.
Population Impacted
The populations most affected by the prescription drug
abuse epidemic are vulnerable adolescents. The high
prevalence of prescription drug abuse by adolescents varies due
to many demographic factors including religion, ethnicity,
gender, income, education level, geographic location, and ease
of access (NIH, 2018a). The motivations associated with
prescription drug abuse also vary between genders. Indeed,
prior literature indicates that female adolescents are more likely
to engage in prescription drugs abuse if they are romantically
involved with a partner who also engages in abuse, and to
improve their academic performance (Papp & Kouros, 2017).
Males were more likely to misuse prescription drugs to selfmedicate or get high (Papp & Kouros, 2017).
Research by Lo, Howell, and Cheng (2013) assessed the
impact of demographic factors of geographical location and
education and found the lack of much needed healthcare,
especially in rural areas, shows a significant association with
the nonmedical use of prescription drugs. Additionally, the lack
of education and misinformation regarding the addictive
properties of prescription drugs is a substantial contributing
factor to the epidemic among adolescents. Understanding the
relationship between demographics and the prevalence of
prescription drug abuse within the community is imperative for
viewing adolescent abuse holistically.
Thesis Statement
The nonmedical use of prescription drugs has become a
national and community healthcare epidemic for the adolescent
population, often leading to life-threatening medical
consequences. This informative paper will examine the abuse
of prescription drugs by adolescents through a holistic lens, as
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well as the role that healthcare professionals have in the
prevention and enablement of prescription drug abuse, and the
future polices implemented to regulate and prevent prescription
drug abuse.
Relationship
Connection to United States Healthcare System
Healthy People 2020, which was launched in 2010, is a
public health initiative concerned with achieving optimal
population health (Shi & Singh, 2019). One of the four
overarching goals of Heathy People 2020 is to “promote quality
of life, healthy development, and healthy behaviors across all
life stages” (Shi & Singh, 2019, p. 82). The topic areas of
Healthy People 2020 focus on substance abuse and adolescent
health, which is directly relevant to the prescription drug abuse
epidemic. Healthy People 2020 uses an action model that
illustrates how interventions influence determinants of health
such as individual behaviors, economic status, and access to
health services (Shi & Singh, 2019). Determinants of health,
such as access, are directly related to the prevalence of
adolescents abusing and misusing prescription drugs. A recent
study by Ford and Lacerenza (2011) examined the relationship
between adolescents misusing prescription drugs and the
availability of the source of diversion and access to healthcare.
They discovered that dependency and misuse of prescription
drugs by adolescents are strongly correlated with ease of access
and availability via either friends, dealers, or physicians (Ford
and Lacerenza, 2011). This correlation supports the significant
need for public health initiatives, such as Healthy People 2020,
that review and establish goals toward reducing the access of
prescription drugs (Shi & Singh, 2019).
Connection to Occupational Science
In occupational science, the term occupation is central to
the discipline. Occupational science is the study of human
behavior regarding how and why people engage in occupations.
Addiction, a common consequence of prescription drug abuse,
prohibits adolescents from participating in everyday valued
occupations. The initial decision to misuse prescription drugs is
voluntary for most individuals, but repeated prescription drug
use leads to chemical changes in the brain which causes
addiction (NIH, 2018b). Indeed, these changes interfere with
one’s ability to resist intense urges to take prescription drugs.
The National Institute on Drug Abuse (2018b) states that “these
brain adaptions often lead to the person becoming less and less
able to derive pleasure from thing they once enjoyed, like food,
sex, or social activities” (para. 5). Addiction controls
adolescents once valued habits and routines and replaces them
with occupations centered around urges to engage in drug
abuse. Prolonged abuse of prescription drugs will affect the
function of developing adolescent brains and impair learning,
judgment, decision-making, memory, stress, and behavior
(NIH, 2018b). Consequently, addiction extinguishes everyday
adolescent interpersonal roles such as friend, student,
son/daughter, and brother/sister.
Connection to Future Role as Healthcare Provider
All healthcare professionals play a crucial role in
identifying and preventing nonmedical use of prescription
drugs. Before healthcare professionals prescribe medication
such as opioids, the patient should be thoroughly educated on

https://encompass.eku.edu/kjus/vol4/iss1/5

21
the addictive nature of the prescription drug. Occupational
therapists, as members of the healthcare team, have an
important role in client education regarding medication
management, medication storage, and medication disposal
(Blum & Fogo, 2018). Occupational therapists should educate
and train clients to modify their habits and routines involved
with the organization and use of medication (Blum & Fogo,
2018). Medication management, within the scope of
occupational therapy, consists of “assessing and treating
cognition and/or executive function, fine motor coordination,
vision, health literacy, and the effectiveness of current
strategies” (Rowe & Breeden, 2018, p. CE-4) to ensure that
clients can accurately count pills and adhere to their prescribed
routines. Indeed, logically, these assessments and interventions
prevent clients from misusing prescription drugs in a dose other
than prescribed.
Aside from medication management, occupational
therapists provide evidence-based, non-pharmacological
interventions for relieving chronic pain (Rowe & Breeden,
2018). Occupational therapists use a biopsychosocial treatment
approach to manage pain rather than treating it with prescribed
medication. After an extensive review of the literature, the
major forms of treatment for chronic pain include education
regarding energy conservation, self-management of pain,
vocational rehabilitation, biofeedback, passive joint
mobilization, modalities, splints, and sleep hygiene, as well as
psychologically-based management strategies such as
cognitive-behavioral therapy (Robinson, Kennedy, & Harmon,
2011). These interventions promote alternative forms of
chronic pain management and are projected to reduce the need
for prescribed medication (Robinson et al., 2011). Chronic pain
significantly affects function, and occupational therapists are in
the unique position to reduce the prescription drug abuse
epidemic due to their client-centered and holistic approach to
treatment of chronic pain.
Relevance
Relevance to Healthcare Policies
The federal government has responded to the current
prescription drug abuse epidemic by creating a five-point,
evidence-based strategy to counteract the current national and
community crisis. This comprehensive framework includes:
improving access to prevention, treatment, and recovery
support services; targeting the availability and distribution of
prescription drugs; strengthening public health data reporting
and collection; supporting cutting-edge research that advances
understanding of pain and addiction; and advancing the nonpharmacological practice of pain management (NIH, 2017).
Under the direction of President Donald Trump, the current
administration recently created a website dedicated to
confronting the opioid crisis in the United States. According the
government website, “drug overdose deaths are now the leading
cause of injury death in the United States” with 63,632 deaths
from drug misuse and overdose (Trump Administration, 2019).
The Trump administration is working to address this issue by
coordinating with healthcare providers to decrease the number
and strength of addictive drug prescriptions.
Pharmaceutical manufacturers are in the process of
creating abuse-deterrent formulations, which are designed to
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prevent individuals from abusing or misusing prescription
drugs. Current approaches being tested for use are physical or
chemical barriers, agonist/antagonists combinations, aversive
substances, delivery systems, and prodrugs (NIH, 2018a).
Additionally, the federal government is pushing pharmaceutical
companies to develop safer, non-addictive medication.
Although safer prescription pharmaceuticals are currently being
developed, the federal government is mandating that physicians
comprehensively screen patients for substance abuse disorders
before providing a prescription for addictive medications
(Weigel, Donovan, Krug, & Dixon, 2007).
The Drug Enforcement Administration (DEA), has created
new federal guidelines that were put into effect in October
2018. The purpose of these guidelines are to restrict physicians’
prescribing habits and limit the distribution and supply of
prescription drugs. These guidelines include restricting the
authorization of refills from a 180-day supply to a 90-day
supply and requiring patients to visit their primary care
physician before receiving a new prescription (Sullivan, 2018).
Medical approaches, assessments, and new guidelines such as
these are projected to dramatically reduce the current
prescription drug abuse epidemic (Sullivan, 2018).
Implications to Healthcare Service Delivery
Preventing the nonmedical use of prescription drugs is a
collaborative effort from physicians, patients, and pharmacists.
Physicians are in the position to identify the nonmedical use of
prescription drugs and take note of rapid increases in the
amount of medication a patient requests and unscheduled
medication refills (NIH, 2018a). Although physicians should be
significantly more cautious due to the recent increase of abuse,
often times, physicians’ overprescribing habits contribute to the
rising rates of prescription drug abuse and overdoses.
Therefore, the federal government and other various
organizations are creating innovative strategies to reduce
physician prescribing habits. In order to counteract the rising
adolescent prescription drug abuse rates, I believe a physician
accountability system needs to be implemented. Indeed, this
online system would guarantee that physicians initially attempt
to prescribe non-addictive forms of medication before
prescribing opioids or other addictive medications. Because of
this system, a physician accountability system would
dramatically reduce the prescription drug abuse epidemic,
however, some responsibility also remains with the patient.
Indeed, the patient has the responsibility of safeguarding
their prescribed medications by taking the appropriate dosage
for the recommended length of time. To counterbalance the
current epidemic, patients need to safely store prescription
medications and never refill any unnecessary prescriptions.
Additionally, if a patient possesses a surplus of prescribed
medication, the patient should properly discard the unused
drugs (NIH, 2018a). Furthermore, before patients refill or
retrieve their prescribed medications, pharmacists have the
responsibility of ensuring patient understanding of the
directions involved when taking their new prescription. This
collaborative effort from physicians, pharmacists, and patients,
along with the physician accountability system, will create
barriers for prescription drug abusers, thus decreasing the
prescription drug abuse epidemic.
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Consequences to Healthcare Service Delivery
The proposed collaborative effort from healthcare
practitioners and new federal guidelines will create many
positive changes to healthcare service delivery, however, like
any new system, some consequences may arise from these
recently
implemented
regulations.
Due
to
these
implementations, it is likely that the number of teenagers
abusing prescription drugs will decrease, as well as the number
of accidental overdoses. However, there are negative
implications to these new guidelines. For example, the action of
making strict federal guidelines for prescribing medication such
as opioids, central nervous system depressants, and stimulates
may prohibit an individual who actually needs these
pharmaceuticals from obtaining them. An article detailing the
DEA states that “the Institute of Medicine estimates that as
many as 100 million Americans suffer from chronic pain,” and
they believe the new refill restrictions on prescription drugs will
prevent Americans who have legitimate needs from receiving
them (Sulllivan, 2018, para 15). Furthermore, because the
guidelines require that patients see a primary care physician
before receiving a new prescription, accessing these drugs now
requires additional trips to the doctor’s office. This change
could potentially cost the healthcare system millions of dollars
and prevent elderly individuals, who have difficulty
transporting to the doctor’s office, from receiving much needed
medication (Sullivan, 2018). Nevertheless, the overall benefits
of these federal restrictions and guidelines on decreasing
prescription drug abuse outweighs the risks.
Conclusion
In conclusion, this informative paper has analyzed the
prescription drug abuse epidemic and its impact on the
adolescent population in a holistic perspective. The magnitude
of this epidemic is viewed as a national and community
healthcare crisis and a major public health issue that is currently
being addressed with new regulations and guidelines by the
federal government and many other organizations. The current
epidemic has relevance to occupational science and impacts
both the health care delivery and the future roles of many
healthcare practitioners, such as occupational therapist,
physicians, and pharmacist. The collaborative effort of
healthcare practitioners and the federal government’s
guidelines will diminish the prevalence of prescription drug
abuse among adolescents. Indeed, decreasing the access and
availability of prescription drugs to adolescents will therein
decrease the number of overall adolescent usage, as well as
decrease the prescription drug related overdoses in the United
States. Our generation of healthcare practitioners can be the
change to end the prescription drug abuse epidemic.
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